Murray, N. P., Aedo, S., Fuentealba, C., Reyes, E., Salazar, A., Lopez, M. A., . . . Guzman, E. (2020). Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study. Urology Journal, 17(3), 262. https://doi.org/10.22037/uj.v0i0.5174
Chicago Style (17th ed.) CitationMurray, Nigel P., Socrates Aedo, Cynthia Fuentealba, Eduardo Reyes, Anibal Salazar, Marco Antonio Lopez, Simona Minzer, Shenda Orrego, and Eghon Guzman. "Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study." Urology Journal 17, no. 3 (2020): 262. https://doi.org/10.22037/uj.v0i0.5174.
MLA (9th ed.) CitationMurray, Nigel P., et al. "Minimal Residual Disease Defines the Risk and Time to Biochemical Failure in Patients with Pt2 and Pt3a Prostate Cancer Treated With Radical Prostatectomy: An Observational Prospective Study." Urology Journal, vol. 17, no. 3, 2020, p. 262, https://doi.org/10.22037/uj.v0i0.5174.